Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Saif Soniwala"'
Autor:
Ajay Dhakal, Roby Antony Thomas, Ellis G Levine, Adam Brufsky, Kazuaki Takabe, Matthew G Hanna, Kristopher Attwood, Austin Miller, Thaer Khoury, Amy P Early, Saif Soniwala, Tracy O’Connor, Mateusz Opyrchal
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 14 (2020)
Background: Despite the approval of mTOR inhibitor everolimus and CDK4/6 inhibitors in the management of hormone-receptor-positive HER2 non-amplified metastatic breast cancer (HR+ HER2-MBC), the optimal sequence of therapy is unclear. There are no cl
Externí odkaz:
https://doaj.org/article/ab6219d74f2a4b79adec209c9ce08069
Autor:
Gregory E. Wilding, Fredrick Hong, Aisha Masood, Kena C. Miller, Sikander Ailawadhi, Margaret Wood, Daniel Iancu, Debbie Manfredi, Taimur Sher, Francisco J. Hernandez-Ilizaliturri, Raman Sood, William Lawrence, Saad Jamshed, Saif Soniwala, Myron S. Czuczman, Kelvin P. Lee, Asher A. Chanan-Khan, Wei Tan
Publikováno v:
British Journal of Haematology. 154:104-110
Novel agents have provided a new foundation for multiple myeloma therapies. When combined with other anti-myeloma agents, these compounds significantly enhance clinical efficacy. High-dose steroids are frequently used in anti-myeloma combination regi
Autor:
Taimur, Sher, Sikander, Ailawadhi, Kena C, Miller, Debbie, Manfredi, Margaret, Wood, Wei, Tan, Gregory, Wilding, Myron S, Czuczman, Francisco J, Hernandez-Ilizaliturri, Fredrick, Hong, Raman, Sood, Saif, Soniwala, William, Lawrence, Saad, Jamshed, Aisha, Masood, Daniel, Iancu, Kelvin, Lee, Asher, Chanan-Khan
Publikováno v:
British journal of haematology. 154(1)
Novel agents have provided a new foundation for multiple myeloma therapies. When combined with other anti-myeloma agents, these compounds significantly enhance clinical efficacy. High-dose steroids are frequently used in anti-myeloma combination regi